✦ LIBER ✦
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
✍ Scribed by Blazing, Michael A.; Giugliano, Robert P.; Cannon, Christopher P.; Musliner, Thomas A.; Tershakovec, Andrew M.; White, Jennifer A.; Reist, Craig; McCagg, Amy; Braunwald, Eugene; Califf, Robert M.
- Book ID
- 122319010
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 1000 KB
- Volume
- 168
- Category
- Article
- ISSN
- 1097-6744
No coin nor oath required. For personal study only.